---
figid: PMC9319476__pharmaceutics-14-01376-g002
figtitle: 'Transporter Regulation in Critical Protective Barriers: Focus on Brain
  and Placenta'
organisms:
- Human immunodeficiency virus 1
- Human immunodeficiency virus
- Subgroup C
- Feline leukemia virus
- Mus musculus
- Rattus norvegicus
- Lareunionomyces loeiensis
- Avena sativa
- Homo sapiens
- NA
- NA
organisms_ner:
- Homo sapiens
- Mus musculus
- Rattus norvegicus
- Danio rerio
pmcid: PMC9319476
filename: pharmaceutics-14-01376-g002.jpg
figlink: /pmc/articles/PMC9319476/figure/pharmaceutics-14-01376-f002/
number: F2
caption: Mechanisms regulating P-gp expression in the blood–brain barrier in Alzheimer’s
  disease. In AD-affected brain regions, P-gp expression and abundance in the endothelial
  cells of the blood-brain–barrier is significantly reduced. Various mechanisms have
  been investigated linking the increased amount of amyloid (A)-peptides Aβ40 and
  Aβ42 to a reduction in P-gp involving NF-κB, and NEDD4-1 mediated ubiquitination
  and the Wnt/β-catenin pathway.
papertitle: 'Transporter Regulation in Critical Protective Barriers: Focus on Brain
  and Placenta.'
reftext: Valerio Taggi, et al. Pharmaceutics. 2022 Jul;14(7):1376.
year: '2022'
doi: 10.3390/pharmaceutics14071376
journal_title: Pharmaceutics
journal_nlm_ta: Pharmaceutics
publisher_name: MDPI
keywords: drug transporters | ABC | SLC | regulation | diseases
automl_pathway: 0.9050984
figid_alias: PMC9319476__F2
figtype: Figure
redirect_from: /figures/PMC9319476__F2
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC9319476__pharmaceutics-14-01376-g002.html
  '@type': Dataset
  description: Mechanisms regulating P-gp expression in the blood–brain barrier in
    Alzheimer’s disease. In AD-affected brain regions, P-gp expression and abundance
    in the endothelial cells of the blood-brain–barrier is significantly reduced.
    Various mechanisms have been investigated linking the increased amount of amyloid
    (A)-peptides Aβ40 and Aβ42 to a reduction in P-gp involving NF-κB, and NEDD4-1
    mediated ubiquitination and the Wnt/β-catenin pathway.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - WNT1
  - WNT2
  - WNT2B
  - WNT3
  - WNT3A
  - WNT4
  - WNT6
  - WNT7A
  - WNT7B
  - WNT8A
  - WNT8B
  - WNT9A
  - WNT9B
  - WNT10A
  - WNT10B
  - WNT11
  - WNT16
  - WNT5A
  - WNT5B
  - RPSA
  - LRP1
  - PTPRA
  - MVP
  - FZD1
  - FZD10
  - FZD2
  - FZD3
  - FZD4
  - FZD5
  - FZD6
  - FZD7
  - FZD8
  - FZD9
  - DVL1
  - DVL1P1
  - DVL2
  - DVL3
  - IFT81
  - AXIN1
  - AXIN2
  - GSK3A
  - GSK3B
  - APC
  - PROC
  - CHKA
  - DKK1
  - CTNNB1
  - NFKB1
  - NEDD4
  - Lrp1
  - Mvp
  - Txlng
  - Dvl1
  - Axin1
  - Gsk3b
  - Apc
  - Dkk1
  - Ctnnb1
  - Nfkb1
  - Nedd4
  - Wnt2
  - Ptpra
  - cby1
  - kita
  - ngfra
  - gsk3ba
  - gsk3ab
  - apc
  - cki
  - dkk1b
  - ctnnb1
---
